GLP3-R 30mg

Description

GLP3-R 30mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

• The listed purity specification is ≥99%; the lot-specific COA documents the tested result for the released lot.
• Released lots are tested by independent third-party laboratories; review the lot-specific report for the methods performed and results obtained.
• Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
• Produced with lot-level traceability to support research documentation and laboratory recordkeeping.

Research Documentation Context

• Supports compound characterization in controlled laboratory settings.
• Provides batch-specific identity and purity documentation for research review.
• Allows lot-level traceability across laboratory documentation workflows.
• Supports comparison of product labeling, analytical documentation, and storage information during research planning.
• Supports analytical review of receptor-pathway research materials within a strictly laboratory-focused context.

Specifications and Documentation

• Certificate of Analysis: Review the lot-specific COA summary in the final product-gallery image and follow its source link or QR code to the original third-party report.
• Material Safety Data Sheet: Coming Soon.
• Handling and Storage Instructions: Coming Soon.
• Product Form: Lyophilized powder.
• Purity Specification: ≥99% purity.
• Intended Use: Laboratory research use only.

GLP3-R 30mg Research Planning

The GLP3-R family is cataloged for controlled laboratory study of coordinated signaling across GLP-1R, GIPR, and GCGR models. Published structural work demonstrates why receptor-by-receptor controls matter: the same triple-agonist research model can be examined through receptor-complex structure, mutation analysis, and cAMP accumulation rather than treated as a single undifferentiated signal.

Why the 30mg Strength Is a Distinct Product Record

This vial contains the highest labeled material amount in the current GLP3-R family. A 30mg record can support laboratory procurement plans that anticipate multi-plate receptor comparisons, repeated analytical runs, or a larger reserve for controlled repeatability work while reducing container count. Projects needing less total material can compare the 5mg, 10mg, and 20mg records. This is a material-planning distinction between product records.

Lot Documentation Review

• Verify that the 30mg vial label and final-gallery COA summary carry the same product and lot identifiers.
• Record the report number, test date, report date, and laboratory sample identifier in the material ledger.
• Review the purity, potency or labeled-content, identity, and mass results alongside the source report’s methods and limitations.
• Open the original independent third-party report through the summary’s QR code or source link before lot acceptance.

Research reference: Li W, et al. Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide. Cell Discovery. 2024;10:77. The study reports receptor-complex structures and receptor-specific cAMP experiments. PMID 39019866.

GLP3-R 30mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.